[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cognitive and Memory Enhancer Drugs Market Analysis 2016-2020 and Forecast 2021-2026

March 2021 | 98 pages | ID: GA4E22B7A74EN
99Strategy

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SNAPSHOT

The global Cognitive and Memory Enhancer Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Cognitive and Memory Enhancer Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • Aricept
  • Exelon
  • Namenda
  • Razadyne
  • Provigil
  • Ritalin
  • Adderall
  • Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
  • Allergan Plc.
  • AlternaScript LLC
  • Ceretropic
  • Eisai Co
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer
  • Shire Plc.
  • Takeda Pharmaceutical Company
  • Teva Pharmaceutical Industries
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
  • Disease Treatment
  • Academic Performance
  • Athletic Performance
  • Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW

1.1 Cognitive and Memory Enhancer Drugs Industry
Figure Cognitive and Memory Enhancer Drugs Industry Chain Structure
  1.1.1 Overview
  1.1.2 Development of Cognitive and Memory Enhancer Drugs
1.2 Market Segment
  1.2.1 Upstream
Table Upstream Segment of Cognitive and Memory Enhancer Drugs
  1.2.2 Downstream
Table Application Segment of Cognitive and Memory Enhancer Drugs
Table Global Cognitive and Memory Enhancer Drugs Market 2016-2026, by Application, in USD Million
  1.2.3 COVID-19 Impact
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 COGNITIVE AND MEMORY ENHANCER DRUGS MARKET BY TYPE

3.1 By Type
  3.1.1 Aricept
Table Major Company List of Aricept
  3.1.2 Exelon
Table Major Company List of Exelon
  3.1.3 Namenda
Table Major Company List of Namenda
  3.1.4 Razadyne
Table Major Company List of Razadyne
  3.1.5 Provigil
Table Major Company List of Provigil
  3.1.6 Ritalin
Table Major Company List of Ritalin
  3.1.7 Adderall
Table Major Company List of Adderall
  3.1.8 Others
Table Major Company List of Others
3.2 Market Size
Table Global Cognitive and Memory Enhancer Drugs Market 2016-2020, by Type, in USD Million
Figure Global Cognitive and Memory Enhancer Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Cognitive and Memory Enhancer Drugs Market 2016-2020, by Type, in Volume
Figure Global Cognitive and Memory Enhancer Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Cognitive and Memory Enhancer Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Cognitive and Memory Enhancer Drugs Market Forecast 2021-2026, by Type, in Volume

4 MAJOR COMPANIES LIST

4.1 Allergan Plc. (Company Profile, Sales Data etc.)
  4.1.1 Allergan Plc. Profile
Table Allergan Plc. Overview List
  4.1.2 Allergan Plc. Products & Services
  4.1.3 Allergan Plc. Business Operation Conditions
Table Business Operation of Allergan Plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 AlternaScript LLC (Company Profile, Sales Data etc.)
  4.2.1 AlternaScript LLC Profile
Table AlternaScript LLC Overview List
  4.2.2 AlternaScript LLC Products & Services
  4.2.3 AlternaScript LLC Business Operation Conditions
Table Business Operation of AlternaScript LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Ceretropic (Company Profile, Sales Data etc.)
  4.3.1 Ceretropic Profile
Table Ceretropic Overview List
  4.3.2 Ceretropic Products & Services
  4.3.3 Ceretropic Business Operation Conditions
Table Business Operation of Ceretropic (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Eisai Co (Company Profile, Sales Data etc.)
  4.4.1 Eisai Co Profile
Table Eisai Co Overview List
  4.4.2 Eisai Co Products & Services
  4.4.3 Eisai Co Business Operation Conditions
Table Business Operation of Eisai Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Johnson & Johnson (Company Profile, Sales Data etc.)
  4.5.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
  4.5.2 Johnson & Johnson Products & Services
  4.5.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Novartis International AG (Company Profile, Sales Data etc.)
  4.6.1 Novartis International AG Profile
Table Novartis International AG Overview List
  4.6.2 Novartis International AG Products & Services
  4.6.3 Novartis International AG Business Operation Conditions
Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Pfizer (Company Profile, Sales Data etc.)
  4.7.1 Pfizer Profile
Table Pfizer Overview List
  4.7.2 Pfizer Products & Services
  4.7.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Shire Plc. (Company Profile, Sales Data etc.)
  4.8.1 Shire Plc. Profile
Table Shire Plc. Overview List
  4.8.2 Shire Plc. Products & Services
  4.8.3 Shire Plc. Business Operation Conditions
Table Business Operation of Shire Plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Takeda Pharmaceutical Company (Company Profile, Sales Data etc.)
  4.9.1 Takeda Pharmaceutical Company Profile
Table Takeda Pharmaceutical Company Overview List
  4.9.2 Takeda Pharmaceutical Company Products & Services
  4.9.3 Takeda Pharmaceutical Company Business Operation Conditions
Table Business Operation of Takeda Pharmaceutical Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Teva Pharmaceutical Industries (Company Profile, Sales Data etc.)
  4.10.1 Teva Pharmaceutical Industries Profile
Table Teva Pharmaceutical Industries Overview List
  4.10.2 Teva Pharmaceutical Industries Products & Services
  4.10.3 Teva Pharmaceutical Industries Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 MARKET COMPETITION

5.1 Company Competition
Table Global Cognitive and Memory Enhancer Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Cognitive and Memory Enhancer Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Cognitive and Memory Enhancer Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Cognitive and Memory Enhancer Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Cognitive and Memory Enhancer Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Cognitive and Memory Enhancer Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Cognitive and Memory Enhancer Drugs Market Concentration, in 2020
Figure Europe Cognitive and Memory Enhancer Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Cognitive and Memory Enhancer Drugs MMarket Concentration, in 2020
Figure South America Cognitive and Memory Enhancer Drugs Market Concentration, in 2020
Figure Middle East & Africa Cognitive and Memory Enhancer Drugs Market Concentration, in 2020

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Disease Treatment
Figure Cognitive and Memory Enhancer Drugs Demand in Disease Treatment, 2016-2020, in USD Million
Figure Cognitive and Memory Enhancer Drugs Demand in Disease Treatment, 2016-2020, in Volume
  6.1.2 Demand in Academic Performance
Figure Cognitive and Memory Enhancer Drugs Demand in Academic Performance, 2016-2020, in USD Million
Figure Cognitive and Memory Enhancer Drugs Demand in Academic Performance, 2016-2020, in Volume
  6.1.3 Demand in Athletic Performance
Figure Cognitive and Memory Enhancer Drugs Demand in Athletic Performance, 2016-2020, in USD Million
Figure Cognitive and Memory Enhancer Drugs Demand in Athletic Performance, 2016-2020, in Volume
  6.1.4 Demand in Others
Figure Cognitive and Memory Enhancer Drugs Demand in Others, 2016-2020, in USD Million
Figure Cognitive and Memory Enhancer Drugs Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Cognitive and Memory Enhancer Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Cognitive and Memory Enhancer Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Cognitive and Memory Enhancer Drugs Market Share in 2026, by Application, in USD Million
Table Cognitive and Memory Enhancer Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Cognitive and Memory Enhancer Drugs Market Growth 2021-2026, by Application, in Volume
Table Cognitive and Memory Enhancer Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand

7 REGION OPERATION

7.1 Regional Production
Table Cognitive and Memory Enhancer Drugs Production 2016-2020, by Region, in USD Million
Table Cognitive and Memory Enhancer Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Cognitive and Memory Enhancer Drugs Market 2016-2020, by Region, in USD Million
Table Global Cognitive and Memory Enhancer Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Cognitive and Memory Enhancer Drugs Market 2016-2020, by Region, in Volume
Table Global Cognitive and Memory Enhancer Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
Figure North America Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in Volume
  7.3.2 Europe
    7.3.2.1 Overview
Figure Europe Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in Volume
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
Figure Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in Volume
  7.3.4 South America
    7.3.4.1 Overview
Figure South America Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in Volume
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
Figure Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Cognitive and Memory Enhancer Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Cognitive and Memory Enhancer Drugs Market Forecast 2021-2026, by Region, in Volume

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
Table Price Factors List
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview

9 RESEARCH CONCLUSION
LIST OF TABLES
1. Table Upstream Segment of Cognitive and Memory Enhancer Drugs
2. Table Application Segment of Cognitive and Memory Enhancer Drugs
3. Table Global Cognitive and Memory Enhancer Drugs Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Exelon
5. Table Major Company List of Namenda
6. Table Major Company List of Razadyne
7. Table Major Company List of Provigil
8. Table Major Company List of Ritalin
9. Table Major Company List of Adderall
10. Table Major Company List of Others
11. Table Global Cognitive and Memory Enhancer Drugs Market 2016-2020, by Type, in USD Million
12. Table Global Cognitive and Memory Enhancer Drugs Market 2016-2020, by Type, in Volume
13. Table Global Cognitive and Memory Enhancer Drugs Market Forecast 2021-2026, by Type, in USD Million
14. Table Global Cognitive and Memory Enhancer Drugs Market Forecast 2021-2026, by Type, in Volume
15. Table Allergan Plc. Overview List
16. Table Business Operation of Allergan Plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table AlternaScript LLC Overview List
18. Table Business Operation of AlternaScript LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Ceretropic Overview List
20. Table Business Operation of Ceretropic (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Eisai Co Overview List
22. Table Business Operation of Eisai Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Johnson & Johnson Overview List
24. Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Novartis International AG Overview List
26. Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Pfizer Overview List
28. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Shire Plc. Overview List
30. Table Business Operation of Shire Plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table Takeda Pharmaceutical Company Overview List
32. Table Business Operation of Takeda Pharmaceutical Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Teva Pharmaceutical Industries Overview List
34. Table Business Operation of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
35. Table Global Cognitive and Memory Enhancer Drugs Sales Revenue 2016-2020, by Company, in USD Million
36. Table Global Cognitive and Memory Enhancer Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
37. Table Global Cognitive and Memory Enhancer Drugs Sales Volume 2016-2020, by Company, in Volume
38. Table Global Cognitive and Memory Enhancer Drugs Sales Volume Share 2016-2020, by Company, in Volume
39. Table Regional Demand Comparison List
40. Table Major Application in Different Regions
41. Table Cognitive and Memory Enhancer Drugs Demand Forecast 2021-2026, by Application, in USD Million
42. Table Cognitive and Memory Enhancer Drugs Demand Forecast 2021-2026, by Application, in Volume
43. Table Cognitive and Memory Enhancer Drugs Market Growth 2021-2026, by Application, in Volume
44. Table Cognitive and Memory Enhancer Drugs Market Share in 2026, by Application, in Volume
45. Table Cognitive and Memory Enhancer Drugs Production 2016-2020, by Region, in USD Million
46. Table Cognitive and Memory Enhancer Drugs Production 2016-2020, by Region, in Volume
47. Table Global Cognitive and Memory Enhancer Drugs Market 2016-2020, by Region, in USD Million
48. Table Global Cognitive and Memory Enhancer Drugs Market Share 2016-2020, by Region, in USD Million
49. Table Global Cognitive and Memory Enhancer Drugs Market 2016-2020, by Region, in Volume
50. Table Global Cognitive and Memory Enhancer Drugs Market Share 2016-2020, by Region, in Volume
51. Table North America Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in USD Million
52. Table North America Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in Volume
53. Table Europe Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in USD Million
54. Table Europe Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in Volume
55. Table Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in USD Million
56. Table Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in Volume
57. Table South America Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in USD Million
58. Table South America Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in Volume
59. Table Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in USD Million
60. Table Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size 2016-2020, by Country, in Volume
61. Table Cognitive and Memory Enhancer Drugs Market Forecast 2021-2026, by Region, in USD Million
62. Table Cognitive and Memory Enhancer Drugs Market Forecast 2021-2026, by Region, in Volume
63. Table Price Factors List
LIST OF FIGURES
1. Figure Cognitive and Memory Enhancer Drugs Industry Chain Structure
2. Figure Global Cognitive and Memory Enhancer Drugs Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Cognitive and Memory Enhancer Drugs Market Growth 2016-2020, by Type, in Volume
4. Figure Global Cognitive and Memory Enhancer Drugs Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Cognitive and Memory Enhancer Drugs Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Cognitive and Memory Enhancer Drugs Market Concentration, in 2020
7. Figure Europe Cognitive and Memory Enhancer Drugs Market Market Concentration, in 2020
8. Figure Asia-Pacific Cognitive and Memory Enhancer Drugs MMarket Concentration, in 2020
9. Figure South America Cognitive and Memory Enhancer Drugs Market Concentration, in 2020
10. Figure Middle East & Africa Cognitive and Memory Enhancer Drugs Market Concentration, in 2020
11. Figure Cognitive and Memory Enhancer Drugs Demand in Disease Treatment, 2016-2020, in USD Million
12. Figure Cognitive and Memory Enhancer Drugs Demand in Disease Treatment, 2016-2020, in Volume
13. Figure Cognitive and Memory Enhancer Drugs Demand in Academic Performance, 2016-2020, in USD Million
14. Figure Cognitive and Memory Enhancer Drugs Demand in Academic Performance, 2016-2020, in Volume
15. Figure Cognitive and Memory Enhancer Drugs Demand in Athletic Performance, 2016-2020, in USD Million
16. Figure Cognitive and Memory Enhancer Drugs Demand in Athletic Performance, 2016-2020, in Volume
17. Figure Cognitive and Memory Enhancer Drugs Demand in Others, 2016-2020, in USD Million
18. Figure Cognitive and Memory Enhancer Drugs Demand in Others, 2016-2020, in Volume
19. Figure Cognitive and Memory Enhancer Drugs Market Growth 2021-2026, by Application, in USD Million
20. Figure Cognitive and Memory Enhancer Drugs Market Share in 2026, by Application, in USD Million
21. Figure North America Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in USD Million
22. Figure North America Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in Volume
23. Figure Europe Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in USD Million
24. Figure Europe Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in Volume
25. Figure Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in USD Million
26. Figure Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in Volume
27. Figure South America Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in USD Million
28. Figure South America Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in Volume
29. Figure Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in USD Million
30. Figure Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size and Growth 2016-2020, in Volume
31. Figure Marketing Channels Overview


More Publications